Daily News - Monday, 27 April 2026
India to Host Africa Summit, Attend BRICS & Quad Meets in May 2026 (Economic Times)
India is set to intensify its diplomatic outreach in May 2026, with Prime Minister Narendra Modi scheduled to attend the India-Nordic Summit and hold bilateral talks in Italy and the Netherlands, while also hosting the Fourth Africa Summit on May 31 under the Ministry of External Affairs. The BRICS foreign ministers’ meeting will take place in mid‑May, with the West Asia conflict expected to dominate discussions, and India is simultaneously working to align a Quad foreign ministers’ meeting with the visit of US Secretary of State Marco Rubio. Modi has also been invited to the France-Africa Summit in Nairobi (May 11-12), marking the first time a non‑Francophone African nation hosts the event, with focus on youth employment, innovation, and security. India’s cooperation with Nordic nations will emphasize trade, green energy, technology, and maritime security, building on the India-EFTA Trade and Economic Partnership Agreement (signed March 10, 2024, effective October 1, 2025), which aims to generate USD $100 billion (INR ₹8.3 lakh crore) in investment and create one million jobs over 15 years. Bilateral ties with Italy under PM Giorgia Meloni are also strengthening through the Joint Strategic Action Plan 2025-29, covering defence, counterterrorism, renewable energy, and education. Collectively, these engagements highlight India’s push for a multipolar world order, leveraging BRICS, Quad, and Africa partnerships to expand its global influence.
India’s Sun Pharma Buys US-Based Organon in USD $11.75 Bilion Deal (Reuters)
Sun Pharmaceutical Industries Ltd. announced it will acquire Organon & Co. in an all‑cash deal valued at USD $11.75 billion (INR ₹97,900 crore), including debt, marking one of India’s largest outbound acquisitions. Sun Pharma will purchase all outstanding shares of Organon at USD $14 per share, a 24% premium to its last close, and fund the transaction through a mix of cash reserves and bank financing. Organon, which reported a Q4 2025 net loss of USD $205 million (INR ₹1,700 crore) and carries USD $8.6 billion (INR ₹71,700 crore) in debt, brings a portfolio of 70+ products in women’s health and general medicines across 140 countries. Dilip Shanghvi, Executive Chairman of Sun Pharma, emphasized that Organon’s global reach and portfolio are complementary, strengthening Sun’s presence in women’s health, biosimilars, dermatology, oncology, and obesity therapies. Sun Pharma, valued at USD $40 billion (INR ₹3.33 lakh crore), is among the most exposed Indian drugmakers to the US market, where shifting tariff policies under President Donald Trump have pressured margins. The deal is expected to expand Sun’s innovative medicines pipeline and diversify its global footprint under oversight of the Ministry of Commerce & Industry and the Department of Pharmaceuticals.
Government Pay Hike: Extra USD $49 Billion Annually to Boost Spending into Indian Households (Financial Express)
India is witnessing its largest wage shock in 18 years, with the 8th Central Pay Commission (CPC), formally constituted in November 2025, expected to inject USD $46.8-49.3 billion (INR ₹3.7-3.9 lakh crore) annually into household incomes. Covering 50 lakh central government employees and 65-70 lakh pensioners, salaries are projected to rise by 30-50%, under the oversight of the Ministry of Finance and Department of Expenditure. JPMorgan estimates the fiscal cost at nearly four times the 7th CPC of 2016, making this the largest pay driven income boost since the 6th CPC in 2008, which reshaped India’s auto and housing markets. State governments, employing nearly 80 lakh workers, are expected to follow, raising the combined wage bill to USD $88-101 billion (INR ₹7-8 lakh crore) by FY27-28. Simultaneously, the Code on Wages, 2019, effective April 2026, mandates that Basic Pay + Dearness Allowance must form 50% of CTC, creating a 2-3% silent wage hike across 10 crore organised‑sector workers, structurally expanding India’s retirement savings pool via EPFO and NPS. Together, these forces will drive consumption in Tier-2 and Tier-3 towns, boosting demand for housing, autos, FMCG, and financial assets, with ripple effects across Hindustan Unilever, Maruti Suzuki, Bajaj Auto, HDFC, and mutual fund SIP platforms.
Agra’s Leather & Footwear MSMEs Gain Duty-Free Access to New Zealand Market (Fortune India)
India and New Zealand are set to sign a Free Trade Agreement (FTA) on April 27, 2026, which will provide duty‑free access for Indian exports to New Zealand, including Agra’s leather and footwear industry, under the oversight of the Ministry of Commerce & Industry. Commerce Minister Piyush Goyal and New Zealand’s Minister for Trade and Investment Todd McClay announced that the pact aims to double bilateral trade from USD $2.4 billion (INR ₹19,920 crore) and attract USD $20 billion (INR ₹166,000 crore) in investment over 15 years. Agra, one of India’s largest leather clusters dominated by MSMEs, will benefit directly from tariff elimination, boosting competitiveness in footwear and leather goods. The ministers also met with businesses from AYUSH, pharma, medical devices, light engineering, and sports goods, highlighting broader sectoral opportunities. Goyal launched the “Agra: World Capital of Footwear” campaign, positioning the city as a global sourcing hub and employment engine. McClay reaffirmed India as a strategic priority for New Zealand, encouraging joint ventures and deeper investment ties.
